S&P 500

5.469,30

0,39%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Gpc Biotech AG ADS (MM) (GPCB)
Gpc Biotech AG ADS (MM) (GPCB) Notícias

GPCB

Gpc Biotech AG ADS (MM) (GPCB)

Gpc Biotech AG ADS (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:GPCB

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
21/04/2009	11:12	Business Wire	New Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACR	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
25/03/2009	03:40	Business Wire	GPC Biotech Reports Financial Results for Fiscal Year 2008	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
23/02/2009	16:17	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
17/02/2009	22:31	Business Wire	GPC Biotech and Agennix Announce Proposed Merger	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
09/12/2008	07:10	Business Wire	GPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with ...	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
13/11/2008	04:40	Business Wire	GPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
06/11/2008	12:42	Business Wire	GPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New York	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
25/08/2008	16:13	Edgar (US Regulatory)	Gpc Biotech Ag - Report of Foreign Issuer (6-K)	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
06/08/2008	19:01	Business Wire	GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
25/07/2008	17:15	Business Wire	GPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be Withdrawn	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
12/06/2008	05:05	Business Wire	GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
05/06/2008	03:49	Business Wire	GPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New York	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
02/06/2008	04:06	Business Wire	Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemothe	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
02/06/2008	04:05	Business Wire	New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
28/05/2008	04:07	Business Wire	GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
15/05/2008	03:36	Business Wire	GPC Biotech Reports Financial Results for First Quarter 2008	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
31/01/2008	16:42	Edgar (US Regulatory)	Gpc Biotech Ag - Amended Statement of Ownership (SC 13G/A)	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
31/10/2007	01:35	PR Newswire (US)	GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial	NASDAQ:GPCB
31/10/2007	01:27	PR Newswire (US)	Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 Trial	NASDAQ:GPCB
28/09/2007	12:12	Edgar (US Regulatory)	Gpc Biotech Ag (Other) (SC 13G)	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
23/08/2007	19:00	PR Newswire (US)	Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
23/08/2007	02:58	PR Newswire (US)	GPC Biotech Announces Restructuring	NASDAQ:GPCB
21/08/2007	11:41	PR Newswire (US)	Finkelstein Thompson LLP Announces GPC Biotech AG Investigation	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
08/08/2007	03:37	PR Newswire (US)	GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2007	NASDAQ:GPCB
02/08/2007	07:05	PR Newswire (US)	GPC Biotech Schedules Conference Call on August 8th to Discuss First Half 2007 Financial Results	NASDAQ:GPCB
30/07/2007	10:57	PR Newswire (US)	GPC Biotech Withdraws Satraplatin NDA Filed for Accelerated Approval	NASDAQ:GPCB
30/07/2007	10:48	PR Newswire (US)	GPC Biotech Withdraws Satraplatin NDA For Accelerated Approval; Plans to Resubmit With Survival Analysis	NASDAQ:GPCB
27/07/2007	23:30	PR Newswire (US)	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against GPC Biotech	NASDAQ:GPCB	Gpc Biotech AG ADS (MM)
27/07/2007	15:05	PR Newswire (US)	GPC Biotech AG Named in Purported Class Action Lawsuit in the United States	NASDAQ:GPCB
27/07/2007	08:00	PR Newswire (US)	Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency	NASDAQ:GPCB